标题
Therapeutic interventions in severe asthma
作者
关键词
Severe asthma, Phenotypes, Biological therapeutics, Eosinophils
出版物
World Allergy Organization Journal
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-28
DOI
10.1186/s40413-016-0130-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders
- (2016) Gilda Varricchi et al. Current Opinion in Allergy and Clinical Immunology
- Mechanisms of Aeroallergen Immunotherapy
- (2016) Cevdet Ozdemir et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
- (2016) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1
- (2016) Timothy S.C. Hinks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
- (2016) Zafar Zafari et al. PLoS One
- Clinical contraindications to allergen immunotherapy: an EAACI position paper
- (2015) C. Pitsios et al. ALLERGY
- A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma
- (2015) Richard M. Nowak et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults
- (2015) James Fingleton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms
- (2015) Timothy S.C. Hinks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber
- (2015) Hendrik Nolte et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study
- (2015) Aikaterini Detoraki et al. JOURNAL OF ASTHMA
- A novel CRTH2 antagonist: Single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects
- (2015) Martine Géhin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
- (2015) Nicola A Hanania et al. THORAX
- Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis
- (2015) Danilo Di Bona et al. JAMA Internal Medicine
- Childhood asthma prediction models: a systematic review
- (2015) Henriette A Smit et al. Lancet Respiratory Medicine
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials
- (2015) Huib A M Kerstjens et al. Lancet Respiratory Medicine
- Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
- (2015) Laura De Ferrari et al. Expert Review of Respiratory Medicine
- Allergen immunotherapy on the way to product-based evaluation—a WAO statement
- (2015) Claus Bachert et al. World Allergy Organization Journal
- Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459
- (2014) R. Pettipher et al. ALLERGY
- House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma
- (2014) L. Wang et al. ALLERGY
- Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
- (2014) J. P. Arm et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial
- (2014) Holger Mosbech et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders
- (2014) Fanny Legrand et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data
- (2014) Wei Wu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils
- (2014) Karim Dib et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The International Ebola Emergency
- (2014) Sylvie Briand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
- (2014) Chris Newby et al. PLoS One
- SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial
- (2014) F. de Blay et al. RESPIRATORY MEDICINE
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
- (2014) Mario Castro et al. Lancet Respiratory Medicine
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update
- (2014) Giorgio Walter Canonica et al. World Allergy Organization Journal
- Ten-Year Follow-up of Cluster-based Asthma Phenotypes in Adults. A Pooled Analysis of Three Cohorts
- (2013) Anne Boudier et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial
- (2013) H. Neighbour et al. CLINICAL AND EXPERIMENTAL ALLERGY
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma
- (2013) Michael E. Wechsler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language
- (2013) Giovanni Passalacqua et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Specific immunotherapy in asthma: a comprehensive review
- (2013) Giovanni Passalacqua JOURNAL OF ASTHMA
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
- (2013) Giorgio Walter Canonica et al. World Allergy Organization Journal
- Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
- (2012) P. Nair et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
- (2012) Edward Piper et al. EUROPEAN RESPIRATORY JOURNAL
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Novel targeted therapies for eosinophilic disorders
- (2012) Michael E. Wechsler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Patient with Asthma Seeks Medical Advice in 1828, 1928, and 2012
- (2012) Erika von Mutius et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
- (2012) Huib A.M. Kerstjens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Specific immunotherapy: beyond the clinical scores
- (2011) Giovanni Passalacqua ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Specific immunotherapy in asthma: efficacy and safety
- (2011) G. Passalacqua et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial
- (2011) Huib A.M. Kerstjens et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
- (2011) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
- (2011) Jan Lötvall et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
- (2011) Aarti Shikotra et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- SIRP /CD172a Regulates Eosinophil Homeostasis
- (2011) N. Verjan Garcia et al. JOURNAL OF IMMUNOLOGY
- Hypereosinophilia in patients with multiple sclerosis treated with natalizumab
- (2011) M. Abbas et al. NEUROLOGY
- A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
- (2010) Jonathan Corren et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients
- (2010) Mariam Naqvi et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study
- (2010) Maurizio Marogna et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Comparison of allergen immunotherapy practice patterns in the United States and Europe
- (2010) Linda Cox et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
- (2010) S. T. Holgate et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis
- (2010) Danilo Di Bona et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sustained response to mepolizumab in refractory Churg-Strauss syndrome
- (2010) Jean-Emmanuel Kahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System
- (2010) Linda Cox et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trial
- (2010) Stefan Zielen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma
- (2010) Hiroshi Nakajima et al. Immune Network
- The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis
- (2009) E. Compalati et al. ALLERGY
- Allergen immunotherapy and asthma: Efficacy, safety, and other considerations
- (2009) Linda Cox ALLERGY AND ASTHMA PROCEEDINGS
- A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
- (2009) Sally E. Wenzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Allergic Sensitization through the Airway Primes Th17-dependent Neutrophilia and Airway Hyperresponsiveness
- (2009) Rhonda H. Wilson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma
- (2009) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy
- (2009) M. Schiappoli et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors
- (2009) B. S. Bochner CLINICAL AND EXPERIMENTAL ALLERGY
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Asthma Severity According to Global Initiative for Asthma and Its Determinants: An International Study
- (2009) Lucia Cazzoletti et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cluster Analysis and Clinical Asthma Phenotypes
- (2008) Pranab Haldar et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils
- (2008) A. Munitz et al. BLOOD
- Rhinitis and onset of asthma: a longitudinal population-based study
- (2008) Rafea Shaaban et al. LANCET
- Metaanalysis of the Efficacy of Sublingual Immunotherapy in the Treatment of Allergic Asthma in Pediatric Patients, 3 to 18 Years of Age
- (2007) Martin Penagos et al. CHEST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started